CRISPR technology market size to grow by USD 2.88 billion from 2021 to 2026; Addgene Inc. and Agilent Technologies Inc., among others, identified as key vendors

NEW YORK, April 13, 2023 /PRNewswire/ — The CRISPR technology market size is forecasted to increase by USD 2.88 billion from 2021 to 2026, at a CAGR of 19.34%, according to a recent market study by Technavio. The growth of the market will be driven by the increasing demand for the treatment of genetic diseases; rising genome editing across the biotechnology, medical, and agriculture industries; and increasing R&D activities in CRISPR technology. Get a comprehensive report summary describing the market size and forecast along with research methodology. Download the Sample Report

Vendor Analysis

The global CRISPR technology market is fragmented, with the presence of several local, regional, and global vendors. The competition in the market is intense between vertically integrated companies and small vendors and startups that are backed by venture capital funding. The intense competition has forced established vendors to increase their geographical reach and presence by expanding their production facilities and focusing on product development and innovation. The presence of similar offerings and the increasing number of vendors and startups cause price wars and reduce the profitability of vendors. Vendors compete on reliability, superior quality, R&D, timeliness of service, and service optimization. The evolving end-user preference will increase the focus of vendors on product development, which will improve the functionality of synthesized genes. Some of the key vendors covered in the report include:

  • Danaher Corp. – The company offers Alt-R CRISPR-Cas9 System, which is an optimized genome editing solution. It outperforms other CRISPR approaches for producing on-target, double-stranded DNA breaks.
  • Editas Medicine Inc. – The company offers CRISPR, which is a dynamic, versatile tool that allows one to get to and edit nearly any location in the genome.
  • GeneCopoeia Inc. – The company offers GeneHero CRISPR-Cas9 products and services that provide a complete, powerful solution to genome editing needs.
  • GenScript Biotech Corp. – The company offers CRISPR products, services, and resources such as CRISPR gRNA Plasmids, CRISPR sgRNA Services, and Microbial Gene Editing.
  • Addgene Inc.
  • Agilent Technologies Inc.
  • Applied StemCell Inc.
  • Caribou Biosciences Inc.
  • Cellecta Inc.
  • CRISPR Therapeutics AG
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • New England Biolabs Inc.
  • Novartis AG
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • Synthego Corp.
  • Thermo Fisher Scientific Inc.

Why Buy?

  • Add credibility to strategy
  • Analyzes competitor’s offerings
  • Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report

Key Benefits for Industry Players & Stakeholders – 

  • The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
  • It also provides detailed analyses of the market’s competitive landscape and vendors’ product offerings.
  • The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Get a holistic overview of the CRISPR technology market from industry experts to evaluate and develop growth strategies. Download the Sample

Market Segmentation:

The market is segmented by application (biological application, agricultural application, industrial application, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)).

  • The market growth in the biological application segment will be significant over the forecast period. The growth of the segment is driven by the increasing number of biomedical research studies being conducted in universities and research institutions. The increasing awareness about the need for multidisciplinary and interdisciplinary genetics research studies to treat complex diseases and disorders has also boosted biomedical research. In addition, increasing funding for academic biomedical research further drives the growth of the segment.
  • North America will account for 44% of the market growth during the forecast period. The growth of the regional market can be attributed to various factors, including the increasing spending on research, the presence of biotechnology companies and vendors that offer gene-editing services, and the high focus on biomedical research by universities and research institutions. Increased funding for research on CRISPR technology from the private sector is another factor driving the growth of the CRISPR technology market in North America.

Market Dynamics:

Key Drivers:

  • Increasing demand for treatment of genetic diseases
  • Rising genome editing across biotechnology, medical, and agriculture industries
  • Increasing R&D activities in CRISPR technology

The adoption of CRISPR technology is increasing, as it is easy, fast, and inexpensive. Gene editing, with the help of CRISPR technology, can cure sickle cell disease and B-thalassemia, hemophilia, cystic fibrosis, Alzheimer’s, Huntington’s, and Parkinson’s diseases. The development of effective cures for hereditary blindness and cancer using gene therapy is also in the pipeline. In the future, the application areas of CRISPR technology are expected to expand at a much more granular level and enable the easy removal of any misbehaving gene and reduce the effects of deadly genetic diseases such as cystic fibrosis. All these factors are expected to drive the growth of the market in focus.

Major Trends:

  • Advent of CRISPR/CAS9
  • Growing demand for innovative therapeutic gene therapy techniques
  • Increasing venture funding

Significant investments in R&D in the healthcare industry have resulted in the development of advanced technologies such as CRISPR/CAS9. It is a fast, accurate, efficient, and cost-effective genome editing tool and is better than the other techniques of DNA editing. It allows researchers to edit the DNA sequence safely and alter the entire gene function. The use of CRISPR/CAS9 tool is increasing in the cure of genetic defects and the treatment and prevention of diseases such as cancer. Other gene-editing technologies, such as transcription activator-like effector nucleases (TALEN) and zinc-finger nucleases (ZFN) have also been launched in the market. Such developments are expected to positively influence the growth of the market during the forecast period.

Key Challenges:

  • Ethical issues associated with CRISPR Technology
  • Increasing complexity of the gene synthesis process
  • Lack of skilled workforce

Many healthcare professionals do not prefer gene editing, as it alters the entire gene structure of an organism. CRISPR technology specifically targets the egg and sperm cells during germline modification. This enables the inserted gene to be passed on to future generations. Such modifications can have long-term side effects. Hence, the use of such sophisticated gene therapies has triggered an ethical debate, which is challenging the growth of the market.

Gain instant access to 17,000+ market research reports. 
Technavio’s SUBSCRIPTION platform

What are the key data covered in this CRISPR technology market report

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the CRISPR technology market between 2022 and 2026
  • Precise estimation of the size of the CRISPR technology market and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the CRISPR technology market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of CRISPR technology market vendors

Related Reports:

  • The gene therapy market is estimated to grow at a CAGR of 19.91% between 2022 and 2027. The size of the market is forecasted to increase by USD 4,613.9 million. The market is segmented by therapy area (oncology, CNS, ophthalmology, rare diseases, and others), delivery mode (in vivo and ex vivo), and geography (North America, Europe, Asia, and Rest of World (ROW)).
  • The cell and gene therapy market size is expected to increase by USD 9.97 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 20.15%. The market is segmented by type (cell therapy and gene therapy) and geography (North America, Europe, Asia, and Rest of World (ROW)).

CRISPR Technology Market Scope

Report Coverage

Details

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 19.34%

Market growth 2022-2026

USD 2.88 billion

Market structure

Fragmented

YoY growth 2021-2022 (%)

18.25

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, Canada, UK, Germany, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse through Technavio’s Health Care Market Reports

Table of contents

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 12: Market segments
  • 3.4 Market outlook: Forecast for 2021-2026 
    • Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
    • Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
    • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
    • Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers 
    • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers 
    • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants 
    • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes 
    • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
    • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
  • 4.7 Market condition
    • Exhibit 23: Chart on Market condition – Five forces 2021 and 2026

5 Market Segmentation by Application

  • 5.1 Market segments
    • Exhibit 24: Chart on Application – Market share 2021-2026 (%)
    • Exhibit 25: Data Table on Application – Market share 2021-2026 (%)
  • 5.2 Comparison by Application 
    • Exhibit 26: Chart on Comparison by Application
    • Exhibit 27: Data Table on Comparison by Application
  • 5.3 Biological application – Market size and forecast 2021-2026 
    • Exhibit 28: Chart on Biological application – Market size and forecast 2021-2026 ($ million)
    • Exhibit 29: Data Table on Biological application – Market size and forecast 2021-2026 ($ million)
    • Exhibit 30: Chart on Biological application – Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Data Table on Biological application – Year-over-year growth 2021-2026 (%)
  • 5.4 Agricultural application – Market size and forecast 2021-2026 
    • Exhibit 32: Chart on Agricultural application – Market size and forecast 2021-2026 ($ million)
    • Exhibit 33: Data Table on Agricultural application – Market size and forecast 2021-2026 ($ million)
    • Exhibit 34: Chart on Agricultural application – Year-over-year growth 2021-2026 (%)
    • Exhibit 35: Data Table on Agricultural application – Year-over-year growth 2021-2026 (%)
  • 5.5 Industrial application – Market size and forecast 2021-2026 
    • Exhibit 36: Chart on Industrial application – Market size and forecast 2021-2026 ($ million)
    • Exhibit 37: Data Table on Industrial application – Market size and forecast 2021-2026 ($ million)
    • Exhibit 38: Chart on Industrial application – Year-over-year growth 2021-2026 (%)
    • Exhibit 39: Data Table on Industrial application – Year-over-year growth 2021-2026 (%)
  • 5.6 Others – Market size and forecast 2021-2026 
    • Exhibit 40: Chart on Others – Market size and forecast 2021-2026 ($ million)
    • Exhibit 41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
    • Exhibit 42: Chart on Others – Year-over-year growth 2021-2026 (%)
    • Exhibit 43: Data Table on Others – Year-over-year growth 2021-2026 (%)
  • 5.7 Market opportunity by Application 
    • Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview 
    • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation 
    • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison 
    • Exhibit 48: Chart on Geographic comparison
    • Exhibit 49: Data Table on Geographic comparison
  • 7.3 North America – Market size and forecast 2021-2026 
    • Exhibit 50: Chart on North America – Market size and forecast 2021-2026 ($ million)
    • Exhibit 51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
    • Exhibit 52: Chart on North America – Year-over-year growth 2021-2026 (%)
    • Exhibit 53: Data Table on North America – Year-over-year growth 2021-2026 (%)
  • 7.4 Europe – Market size and forecast 2021-2026 
    • Exhibit 54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
    • Exhibit 55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
    • Exhibit 56: Chart on Europe – Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
  • 7.5 Asia – Market size and forecast 2021-2026 
    • Exhibit 58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
    • Exhibit 59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
    • Exhibit 60: Chart on Asia – Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) – Market size and forecast 2021-2026 
    • Exhibit 62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
    • Exhibit 63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
    • Exhibit 64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
    • Exhibit 65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
  • 7.7 US – Market size and forecast 2021-2026 
    • Exhibit 66: Chart on US – Market size and forecast 2021-2026 ($ million)
    • Exhibit 67: Data Table on US – Market size and forecast 2021-2026 ($ million)
    • Exhibit 68: Chart on US – Year-over-year growth 2021-2026 (%)
    • Exhibit 69: Data Table on US – Year-over-year growth 2021-2026 (%)
  • 7.8 UK – Market size and forecast 2021-2026 
    • Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
    • Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
    • Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
    • Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
  • 7.9 Canada – Market size and forecast 2021-2026 
    • Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
    • Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
    • Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
    • Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
  • 7.10 Germany – Market size and forecast 2021-2026 
    • Exhibit 78: Chart on Germany – Market size and forecast 2021-2026 ($ million)
    • Exhibit 79: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
    • Exhibit 80: Chart on Germany – Year-over-year growth 2021-2026 (%)
    • Exhibit 81: Data Table on Germany – Year-over-year growth 2021-2026 (%)
  • 7.11 Japan – Market size and forecast 2021-2026 
    • Exhibit 82: Chart on Japan – Market size and forecast 2021-2026 ($ million)
    • Exhibit 83: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
    • Exhibit 84: Chart on Japan – Year-over-year growth 2021-2026 (%)
    • Exhibit 85: Data Table on Japan – Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity by geography 
    • Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

  • 8.3 Impact of drivers and challenges 
    • Exhibit 87: Impact of drivers and challenges in 2021 and 2026

9 Vendor Landscape

  • 9.2 Vendor landscape
    • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
    • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
    • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
    • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors 
    • Exhibit 92: Matrix on vendor position and classification
  • 10.3 Danaher Corp.
    • Exhibit 93: Danaher Corp. – Overview
    • Exhibit 94: Danaher Corp. – Business segments
    • Exhibit 95: Danaher Corp. – Key news
    • Exhibit 96: Danaher Corp. – Key offerings
    • Exhibit 97: Danaher Corp. – Segment focus
  • 10.4 Editas Medicine Inc.
    • Exhibit 98: Editas Medicine Inc. – Overview
    • Exhibit 99: Editas Medicine Inc. – Product / Service
    • Exhibit 100: Editas Medicine Inc. – Key offerings
  • 10.5 GeneCopoeia Inc.
    • Exhibit 101: GeneCopoeia Inc. – Overview
    • Exhibit 102: GeneCopoeia Inc. – Product / Service
    • Exhibit 103: GeneCopoeia Inc. – Key offerings
  • 10.6 GenScript Biotech Corp. 
    • Exhibit 104: GenScript Biotech Corp. – Overview
    • Exhibit 105: GenScript Biotech Corp. – Business segments
    • Exhibit 106: GenScript Biotech Corp. – Key news
    • Exhibit 107: GenScript Biotech Corp. – Key offerings
    • Exhibit 108: GenScript Biotech Corp. – Segment focus
  • 10.7 Intellia Therapeutics Inc. 
    • Exhibit 109: Intellia Therapeutics Inc. – Overview
    • Exhibit 110: Intellia Therapeutics Inc. – Business segments
    • Exhibit 111: Intellia Therapeutics Inc. – Key offerings
    • Exhibit 112: Intellia Therapeutics Inc. – Segment focus
  • 10.8 Lonza Group Ltd.
    • Exhibit 113: Lonza Group Ltd. – Overview
    • Exhibit 114: Lonza Group Ltd. – Product / Service
    • Exhibit 115: Lonza Group Ltd. – Key news
    • Exhibit 116: Lonza Group Ltd. – Key offerings
  • 10.9 New England Biolabs Inc. 
    • Exhibit 117: New England Biolabs Inc. – Overview
    • Exhibit 118: New England Biolabs Inc. – Product / Service
    • Exhibit 119: New England Biolabs Inc. – Key news
    • Exhibit 120: New England Biolabs Inc. – Key offerings
  • 10.10 OriGene Technologies Inc. 
    • Exhibit 121: OriGene Technologies Inc. – Overview
    • Exhibit 122: OriGene Technologies Inc. – Product / Service
    • Exhibit 123: OriGene Technologies Inc. – Key offerings
  • 10.11 PerkinElmer Inc.
    • Exhibit 124: PerkinElmer Inc. – Overview
    • Exhibit 125: PerkinElmer Inc. – Business segments
    • Exhibit 126: PerkinElmer Inc. – Key news
    • Exhibit 127: PerkinElmer Inc. – Key offerings
    • Exhibit 128: PerkinElmer Inc. – Segment focus
  • 10.12 Thermo Fisher Scientific Inc. 
    • Exhibit 129: Thermo Fisher Scientific Inc. – Overview
    • Exhibit 130: Thermo Fisher Scientific Inc. – Business segments
    • Exhibit 131: Thermo Fisher Scientific Inc. – Key news
    • Exhibit 132: Thermo Fisher Scientific Inc. – Key offerings
    • Exhibit 133: Thermo Fisher Scientific Inc. – Segment focus

11 Appendix

  • 11.2 Inclusions and exclusions checklist 
    • Exhibit 134: Inclusions checklist
    • Exhibit 135: Exclusions checklist
  • 11.3 Currency conversion rates for US$ 
    • Exhibit 136: Currency conversion rates for US$
  • 11.4 Research methodology
    • Exhibit 137: Research methodology
    • Exhibit 138: Validation techniques employed for market sizing
    • Exhibit 139: Information sources
  • 11.5 List of abbreviations 
    • Exhibit 140: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

Read more here: Source link